NDC Package 45802-078-30 Brimonidine

Gel Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
45802-078-30
Package Description:
1 BOTTLE, PUMP in 1 CARTON / 30 g in 1 BOTTLE, PUMP
Product Code:
Proprietary Name:
Brimonidine
Non-Proprietary Name:
Brimonidine
Substance Name:
Brimonidine Tartrate
Usage Information:
This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.
11-Digit NDC Billing Format:
45802007830
Billing Unit:
GM - Billing unit of "gram" is used when a product is measured by its weight.
NDC to RxNorm Crosswalk:
30 GM
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Padagis Israel Pharmaceuticals Ltd
Dosage Form:
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route(s):
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
ANDA209158
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
01-01-2023
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 45802-078-30?

The NDC Packaged Code 45802-078-30 is assigned to a package of 1 bottle, pump in 1 carton / 30 g in 1 bottle, pump of Brimonidine, a human prescription drug labeled by Padagis Israel Pharmaceuticals Ltd. The product's dosage form is gel and is administered via topical form.

Is NDC 45802-078 included in the NDC Directory?

Yes, Brimonidine with product code 45802-078 is active and included in the NDC Directory. The product was first marketed by Padagis Israel Pharmaceuticals Ltd on January 01, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 45802-078-30?

The contents of this package are billed per "gm or gram", products billed per gram are products measured by weight. The calculated billable units for this package is 30.

What is the 11-digit format for NDC 45802-078-30?

The 11-digit format is 45802007830. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-245802-078-305-4-245802-0078-30